AI assistant
Sending…
AMGEN INC — Director's Dealing 2020
Feb 11, 2020
29819_dirs_2020-02-10_5e7ba922-365a-40b0-8d01-ee6579c808f8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2020-02-06
Reporting Person: Williams R Sanders (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-06 | Common Stock | S | 425 | $233.72 | Disposed | 4988 | Direct |
Footnotes
F1: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
More from AMGEN INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7